Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 2

3(42.9%)

Phase 3

2(28.6%)

N/A

1(14.3%)

Phase 1

1(14.3%)

7Total

Phase 2(3)

Phase 3(2)

N/A(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04530318Phase 2Active Not Recruiting

Dendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis

Role: lead

NCT03619278Phase 1Withdrawn

Evaluating a Combination of Immune-based Therapies to Achieve a Remission of HIV Infection

Role: lead

NCT03311945Phase 3Completed

Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM

Role: lead

NCT02652793Not ApplicableCompleted

Simplification From Tenofovir Plus Lamivudine or Emtricitabine Plus Ritonavir-Boosted-Protease Inhibitor to Ritonavir-Boosted-Atazanavir Plus Lamivudine in Virologically-Suppressed-HIVInfected Adults With Osteopenia

Role: lead

NCT03333083Phase 3Terminated

Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen

Role: lead

NCT03780673Phase 2Completed

Efficacy of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis to Prevent ACLF Development

Role: lead

NCT03150459Phase 2Completed

Simvastatin Plus Rifaximin in Decompensated Cirrhosis

Role: lead

All 7 trials loaded